US FDA Plans Streamlining Infant Formula Approval Process To Expand Supply Chain

FDA “determined a more streamlined pathway” using information it's received for  products available under enforcement discretion “would help provide for the long-term availability and marketing of many” of those products.

• Source: Shutterstock

Results from the US Food and Drug Administration’s and manufacturers’ responses this year to an infant formula shortage pointed the agency to plan to streamline its procedures for allowing additional firms to market formula.

The agency on 6 July announced it has “determined that a more streamlined pathway” using information it has received for...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Supply Chain

More from HBW Insight